Frank Rimerman Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
VCM
N
Frank Rimerman Advisors's REGN Position: Q1 2026 in Review
Frank Rimerman Advisors reduced its Regeneron Pharmaceuticals (REGN) stake by 0.3% in Q1 2026, selling an estimated $2.3K and leaving 1,002 shares worth $774K. The position accounts for 0.05% of the portfolio, ranked #294.
Frank Rimerman Advisors first reported a position in REGN in Q4 2023 and has held it in 10 quarters since. The position peaked at $776K in Q4 2025. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Frank Rimerman Advisors held 1,002 shares of Regeneron Pharmaceuticals worth $774K as of Q1 2026.
- Frank Rimerman Advisors sold 3 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $2.3K.
- Regeneron Pharmaceuticals made up 0.05% of Frank Rimerman Advisors's portfolio in Q1 2026, its #294 holding.
- Frank Rimerman Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
- Frank Rimerman Advisors's Regeneron Pharmaceuticals position peaked at $776K in Q4 2025.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Frank Rimerman Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.